nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CACNA1S—pes—peripheral nervous system neoplasm	0.0778	0.371	CbGeAlD
Isradipine—CACNA1D—cochlear duct of membranous labyrinth—peripheral nervous system neoplasm	0.0555	0.265	CbGeAlD
Isradipine—CACNA1D—cochlea—peripheral nervous system neoplasm	0.0281	0.134	CbGeAlD
Isradipine—CACNA1D—internal ear—peripheral nervous system neoplasm	0.0267	0.127	CbGeAlD
Isradipine—CACNA1H—NCAM1 interactions—NCAM1—peripheral nervous system neoplasm	0.00583	0.0409	CbGpPWpGaD
Isradipine—CACNA2D1—brainstem—peripheral nervous system neoplasm	0.00522	0.0249	CbGeAlD
Isradipine—CACNA1S—NCAM1 interactions—NCAM1—peripheral nervous system neoplasm	0.00495	0.0347	CbGpPWpGaD
Isradipine—CACNB2—NCAM1 interactions—NCAM1—peripheral nervous system neoplasm	0.00424	0.0297	CbGpPWpGaD
Isradipine—CACNA1D—NCAM1 interactions—NCAM1—peripheral nervous system neoplasm	0.00402	0.0282	CbGpPWpGaD
Isradipine—Clevidipine—BCHE—peripheral nervous system neoplasm	0.00375	0.351	CrCbGaD
Isradipine—CACNA2D2—cerebellum—peripheral nervous system neoplasm	0.00358	0.0171	CbGeAlD
Isradipine—CACNA1C—NCAM1 interactions—NCAM1—peripheral nervous system neoplasm	0.00353	0.0247	CbGpPWpGaD
Isradipine—CACNA1H—NCAM signaling for neurite out-growth—NCAM1—peripheral nervous system neoplasm	0.00343	0.024	CbGpPWpGaD
Isradipine—CACNA1S—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.00292	0.0205	CbGpPWpGaD
Isradipine—CACNA1S—NCAM signaling for neurite out-growth—NCAM1—peripheral nervous system neoplasm	0.00291	0.0204	CbGpPWpGaD
Isradipine—CACNA1H—cerebellum—peripheral nervous system neoplasm	0.0029	0.0138	CbGeAlD
Isradipine—CACNB2—cerebellum—peripheral nervous system neoplasm	0.00274	0.0131	CbGeAlD
Isradipine—CACNA2D2—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.0026	0.0182	CbGpPWpGaD
Isradipine—CACNA2D1—cerebellum—peripheral nervous system neoplasm	0.00257	0.0123	CbGeAlD
Isradipine—CACNB2—NCAM signaling for neurite out-growth—NCAM1—peripheral nervous system neoplasm	0.00249	0.0175	CbGpPWpGaD
Isradipine—CACNA1D—cerebellum—peripheral nervous system neoplasm	0.00239	0.0114	CbGeAlD
Isradipine—CACNA1D—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.00237	0.0166	CbGpPWpGaD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—NCAM1—peripheral nervous system neoplasm	0.00236	0.0165	CbGpPWpGaD
Isradipine—CACNA1C—cerebellum—peripheral nervous system neoplasm	0.00221	0.0105	CbGeAlD
Isradipine—CACNA2D2—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.0021	0.0147	CbGpPWpGaD
Isradipine—CACNA1C—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.00208	0.0146	CbGpPWpGaD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—NCAM1—peripheral nervous system neoplasm	0.00208	0.0145	CbGpPWpGaD
Isradipine—CACNA2D2—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.00205	0.0143	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00201	0.0141	CbGpPWpGaD
Isradipine—CACNB2—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.00178	0.0125	CbGpPWpGaD
Isradipine—CACNA1H—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.00171	0.012	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00171	0.012	CbGpPWpGaD
Isradipine—CACNA1D—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.00169	0.0118	CbGpPWpGaD
Isradipine—CACNA2D2—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.00165	0.0115	CbGpPWpGaD
Isradipine—CACNA1H—NCAM signaling for neurite out-growth—PTPN11—peripheral nervous system neoplasm	0.00152	0.0106	CbGpPWpGaD
Isradipine—CACNA1C—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.00149	0.0104	CbGpPWpGaD
Isradipine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00148	0.0103	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00146	0.0103	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00144	0.0101	CbGpPWpGaD
Isradipine—CACNB2—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00144	0.0101	CbGpPWpGaD
Isradipine—Nisoldipine—ABCB1—peripheral nervous system neoplasm	0.00141	0.132	CrCbGaD
Isradipine—CACNB2—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.0014	0.00983	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00139	0.00972	CbGpPWpGaD
Isradipine—CACNA1D—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00136	0.00953	CbGpPWpGaD
Isradipine—CACNA1D—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.00133	0.00931	CbGpPWpGaD
Isradipine—Nitrendipine—ABCB1—peripheral nervous system neoplasm	0.00132	0.123	CrCbGaD
Isradipine—CACNA1S—NCAM signaling for neurite out-growth—PTPN11—peripheral nervous system neoplasm	0.00129	0.00901	CbGpPWpGaD
Isradipine—CACNA2D2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.00127	0.00891	CbGpPWpGaD
Isradipine—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00125	0.00878	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00122	0.00854	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00122	0.00854	CbGpPWpGaD
Isradipine—CACNA1C—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00119	0.00837	CbGpPWpGaD
Isradipine—CACNA1C—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.00117	0.00818	CbGpPWpGaD
Isradipine—Amlodipine—ABCB1—peripheral nervous system neoplasm	0.00114	0.106	CrCbGaD
Isradipine—CACNB2—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.00113	0.00791	CbGpPWpGaD
Isradipine—CACNB2—NCAM signaling for neurite out-growth—PTPN11—peripheral nervous system neoplasm	0.0011	0.00772	CbGpPWpGaD
Isradipine—CACNA1D—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.00107	0.00749	CbGpPWpGaD
Isradipine—Felodipine—ABCB1—peripheral nervous system neoplasm	0.00105	0.0983	CrCbGaD
Isradipine—CACNB2—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00105	0.00732	CbGpPWpGaD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—PTPN11—peripheral nervous system neoplasm	0.00104	0.00731	CbGpPWpGaD
Isradipine—Nifedipine—ABCB1—peripheral nervous system neoplasm	0.00102	0.0951	CrCbGaD
Isradipine—Nicardipine—ABCB1—peripheral nervous system neoplasm	0.000999	0.0936	CrCbGaD
Isradipine—CACNA1D—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00099	0.00693	CbGpPWpGaD
Isradipine—CACNA1S—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000988	0.00692	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000983	0.00689	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000982	0.00688	CbGpPWpGaD
Isradipine—CACNA2D2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000975	0.00683	CbGpPWpGaD
Isradipine—CACNA1C—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.00094	0.00658	CbGpPWpGaD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—PTPN11—peripheral nervous system neoplasm	0.000917	0.00643	CbGpPWpGaD
Isradipine—CACNA1H—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	0.000911	0.00638	CbGpPWpGaD
Isradipine—CACNB2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000872	0.00611	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00087	0.00609	CbGpPWpGaD
Isradipine—CACNA1H—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.000854	0.00598	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000834	0.00585	CbGpPWpGaD
Isradipine—CACNA1S—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000818	0.00573	CbGpPWpGaD
Isradipine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000808	0.00566	CbGpPWpGaD
Isradipine—CACNA1D—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000802	0.00562	CbGpPWpGaD
Isradipine—CACNA1S—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	0.000773	0.00542	CbGpPWpGaD
Isradipine—Malaise—Etoposide—peripheral nervous system neoplasm	0.000745	0.00117	CcSEcCtD
Isradipine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000745	0.00117	CcSEcCtD
Isradipine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00074	0.00116	CcSEcCtD
Isradipine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000739	0.00116	CcSEcCtD
Isradipine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000736	0.00116	CcSEcCtD
Isradipine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000736	0.00116	CcSEcCtD
Isradipine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000731	0.00115	CcSEcCtD
Isradipine—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000729	0.00115	CcSEcCtD
Isradipine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000726	0.00114	CcSEcCtD
Isradipine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000726	0.00114	CcSEcCtD
Isradipine—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000726	0.00114	CcSEcCtD
Isradipine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000725	0.00114	CcSEcCtD
Isradipine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000725	0.00114	CcSEcCtD
Isradipine—Rash—Topotecan—peripheral nervous system neoplasm	0.000725	0.00114	CcSEcCtD
Isradipine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000724	0.00114	CcSEcCtD
Isradipine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000724	0.00114	CcSEcCtD
Isradipine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000722	0.00113	CcSEcCtD
Isradipine—Cough—Etoposide—peripheral nervous system neoplasm	0.000721	0.00113	CcSEcCtD
Isradipine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000721	0.00113	CcSEcCtD
Isradipine—Headache—Topotecan—peripheral nervous system neoplasm	0.00072	0.00113	CcSEcCtD
Isradipine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000719	0.00113	CcSEcCtD
Isradipine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000719	0.00113	CcSEcCtD
Isradipine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000719	0.00113	CcSEcCtD
Isradipine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000718	0.00113	CcSEcCtD
Isradipine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000718	0.00113	CcSEcCtD
Isradipine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000718	0.00113	CcSEcCtD
Isradipine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000718	0.00113	CcSEcCtD
Isradipine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000715	0.00112	CcSEcCtD
Isradipine—CACNB2—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000715	0.00501	CbGpPWpGaD
Isradipine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000715	0.00112	CcSEcCtD
Isradipine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000714	0.00112	CcSEcCtD
Isradipine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000714	0.00112	CcSEcCtD
Isradipine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000712	0.00112	CcSEcCtD
Isradipine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000712	0.00112	CcSEcCtD
Isradipine—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000712	0.00112	CcSEcCtD
Isradipine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000712	0.00112	CcSEcCtD
Isradipine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00071	0.00112	CcSEcCtD
Isradipine—Rash—Melphalan—peripheral nervous system neoplasm	0.000709	0.00111	CcSEcCtD
Isradipine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000709	0.00111	CcSEcCtD
Isradipine—CACNA1C—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000705	0.00494	CbGpPWpGaD
Isradipine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000703	0.0011	CcSEcCtD
Isradipine—CACNA1H—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000702	0.00492	CbGpPWpGaD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000699	0.0011	CcSEcCtD
Isradipine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000695	0.00109	CcSEcCtD
Isradipine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000695	0.00109	CcSEcCtD
Isradipine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000688	0.00108	CcSEcCtD
Isradipine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000686	0.00108	CcSEcCtD
Isradipine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000683	0.00107	CcSEcCtD
Isradipine—CACNA1D—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000677	0.00475	CbGpPWpGaD
Isradipine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000677	0.00106	CcSEcCtD
Isradipine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000677	0.00106	CcSEcCtD
Isradipine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000674	0.00106	CcSEcCtD
Isradipine—CACNB2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000673	0.00471	CbGpPWpGaD
Isradipine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000671	0.00105	CcSEcCtD
Isradipine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000669	0.00105	CcSEcCtD
Isradipine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000668	0.00105	CcSEcCtD
Isradipine—CACNB2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000668	0.00468	CbGpPWpGaD
Isradipine—CACNA1H—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	0.000667	0.00467	CbGpPWpGaD
Isradipine—CACNA1D—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000664	0.00465	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000663	0.00465	CbGpPWpGaD
Isradipine—CACNB2—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	0.000663	0.00464	CbGpPWpGaD
Isradipine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000661	0.00104	CcSEcCtD
Isradipine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00066	0.00104	CcSEcCtD
Isradipine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000658	0.00103	CcSEcCtD
Isradipine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000657	0.00103	CcSEcCtD
Isradipine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000656	0.00103	CcSEcCtD
Isradipine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000655	0.00103	CcSEcCtD
Isradipine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000652	0.00102	CcSEcCtD
Isradipine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000648	0.00102	CcSEcCtD
Isradipine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000643	0.00101	CcSEcCtD
Isradipine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00064	0.001	CcSEcCtD
Isradipine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000638	0.001	CcSEcCtD
Isradipine—CACNA1D—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000637	0.00446	CbGpPWpGaD
Isradipine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000636	0.000998	CcSEcCtD
Isradipine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00063	0.00099	CcSEcCtD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	0.000628	0.0044	CbGpPWpGaD
Isradipine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00062	0.000973	CcSEcCtD
Isradipine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000614	0.000964	CcSEcCtD
Isradipine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000611	0.00096	CcSEcCtD
Isradipine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000607	0.000953	CcSEcCtD
Isradipine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000607	0.000953	CcSEcCtD
Isradipine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000606	0.000951	CcSEcCtD
Isradipine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000605	0.00095	CcSEcCtD
Isradipine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000601	0.000944	CcSEcCtD
Isradipine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.0006	0.000941	CcSEcCtD
Isradipine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000599	0.000941	CcSEcCtD
Isradipine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000597	0.000938	CcSEcCtD
Isradipine—CACNA1S—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000595	0.00417	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000595	0.00417	CbGpPWpGaD
Isradipine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000593	0.000931	CcSEcCtD
Isradipine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000592	0.00093	CcSEcCtD
Isradipine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000591	0.000928	CcSEcCtD
Isradipine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000588	0.000923	CcSEcCtD
Isradipine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000586	0.000921	CcSEcCtD
Isradipine—CACNA1C—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000584	0.00409	CbGpPWpGaD
Isradipine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000582	0.000914	CcSEcCtD
Isradipine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000581	0.000913	CcSEcCtD
Isradipine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000577	0.000906	CcSEcCtD
Isradipine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000571	0.000897	CcSEcCtD
Isradipine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00057	0.000894	CcSEcCtD
Isradipine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000568	0.000892	CcSEcCtD
Isradipine—CACNA1S—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	0.000566	0.00396	CbGpPWpGaD
Isradipine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.000882	CcSEcCtD
Isradipine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000561	0.00088	CcSEcCtD
Isradipine—CACNA1C—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00056	0.00392	CbGpPWpGaD
Isradipine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00056	0.000879	CcSEcCtD
Isradipine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000556	0.000873	CcSEcCtD
Isradipine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000553	0.000869	CcSEcCtD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	0.000552	0.00386	CbGpPWpGaD
Isradipine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000551	0.000864	CcSEcCtD
Isradipine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000549	0.000863	CcSEcCtD
Isradipine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000548	0.000861	CcSEcCtD
Isradipine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000545	0.000855	CcSEcCtD
Isradipine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000544	0.000855	CcSEcCtD
Isradipine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000542	0.000851	CcSEcCtD
Isradipine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000541	0.00085	CcSEcCtD
Isradipine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000536	0.000841	CcSEcCtD
Isradipine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000836	CcSEcCtD
Isradipine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000529	0.000831	CcSEcCtD
Isradipine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000529	0.000831	CcSEcCtD
Isradipine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000528	0.000829	CcSEcCtD
Isradipine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000525	0.000825	CcSEcCtD
Isradipine—Rash—Vincristine—peripheral nervous system neoplasm	0.000525	0.000824	CcSEcCtD
Isradipine—CACNA1S—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000525	0.00367	CbGpPWpGaD
Isradipine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000524	0.000823	CcSEcCtD
Isradipine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000823	CcSEcCtD
Isradipine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000523	0.000821	CcSEcCtD
Isradipine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000522	0.000819	CcSEcCtD
Isradipine—Headache—Vincristine—peripheral nervous system neoplasm	0.000522	0.000819	CcSEcCtD
Isradipine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000519	0.000814	CcSEcCtD
Isradipine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000513	0.000806	CcSEcCtD
Isradipine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000513	0.000805	CcSEcCtD
Isradipine—CACNB2—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00051	0.00358	CbGpPWpGaD
Isradipine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000504	0.000791	CcSEcCtD
Isradipine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.000787	CcSEcCtD
Isradipine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000781	CcSEcCtD
Isradipine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000494	0.000776	CcSEcCtD
Isradipine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000494	0.000775	CcSEcCtD
Isradipine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000494	0.000775	CcSEcCtD
Isradipine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.000773	CcSEcCtD
Isradipine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00049	0.000769	CcSEcCtD
Isradipine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000487	0.00341	CbGpPWpGaD
Isradipine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.000763	CcSEcCtD
Isradipine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000762	CcSEcCtD
Isradipine—CACNB2—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	0.000485	0.0034	CbGpPWpGaD
Isradipine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000484	0.00076	CcSEcCtD
Isradipine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.00076	CcSEcCtD
Isradipine—CACNA1D—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000483	0.00339	CbGpPWpGaD
Isradipine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000483	0.000758	CcSEcCtD
Isradipine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000483	0.000758	CcSEcCtD
Isradipine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000755	CcSEcCtD
Isradipine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00048	0.000753	CcSEcCtD
Isradipine—CACNA2D2—Metabolism—GNS—peripheral nervous system neoplasm	0.000479	0.00336	CbGpPWpGaD
Isradipine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000477	0.000749	CcSEcCtD
Isradipine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000474	0.000745	CcSEcCtD
Isradipine—CACNA1H—Axon guidance—MET—peripheral nervous system neoplasm	0.00047	0.00329	CbGpPWpGaD
Isradipine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000468	0.000735	CcSEcCtD
Isradipine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000732	CcSEcCtD
Isradipine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000464	0.000729	CcSEcCtD
Isradipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000464	0.00325	CbGpPWpGaD
Isradipine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000464	0.000728	CcSEcCtD
Isradipine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000463	0.000727	CcSEcCtD
Isradipine—CACNA1H—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	0.000462	0.00324	CbGpPWpGaD
Isradipine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000461	0.000725	CcSEcCtD
Isradipine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000722	CcSEcCtD
Isradipine—CACNA2D2—Metabolism—NME1—peripheral nervous system neoplasm	0.00046	0.00322	CbGpPWpGaD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	0.000459	0.00322	CbGpPWpGaD
Isradipine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000457	0.000717	CcSEcCtD
Isradipine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000457	0.000717	CcSEcCtD
Isradipine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000455	0.000714	CcSEcCtD
Isradipine—CACNB2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000455	0.00318	CbGpPWpGaD
Isradipine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00045	0.000706	CcSEcCtD
Isradipine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000704	CcSEcCtD
Isradipine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.000701	CcSEcCtD
Isradipine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000446	0.0007	CcSEcCtD
Isradipine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000699	CcSEcCtD
Isradipine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000698	CcSEcCtD
Isradipine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000444	0.000697	CcSEcCtD
Isradipine—CACNA2D2—Metabolism—COX2—peripheral nervous system neoplasm	0.000442	0.0031	CbGpPWpGaD
Isradipine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000437	0.000687	CcSEcCtD
Isradipine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000437	0.000685	CcSEcCtD
Isradipine—CACNA1H—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000435	0.00304	CbGpPWpGaD
Isradipine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000677	CcSEcCtD
Isradipine—CACNA1D—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00043	0.00302	CbGpPWpGaD
Isradipine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00043	0.000675	CcSEcCtD
Isradipine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000429	0.000673	CcSEcCtD
Isradipine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.000673	CcSEcCtD
Isradipine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000428	0.000672	CcSEcCtD
Isradipine—CACNA1D—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000426	0.00298	CbGpPWpGaD
Isradipine—Rash—Etoposide—peripheral nervous system neoplasm	0.000425	0.000668	CcSEcCtD
Isradipine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000425	0.000667	CcSEcCtD
Isradipine—CACNA1C—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000425	0.00298	CbGpPWpGaD
Isradipine—Headache—Etoposide—peripheral nervous system neoplasm	0.000422	0.000663	CcSEcCtD
Isradipine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.00066	CcSEcCtD
Isradipine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000418	0.000656	CcSEcCtD
Isradipine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000416	0.000654	CcSEcCtD
Isradipine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000652	CcSEcCtD
Isradipine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000651	CcSEcCtD
Isradipine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000651	CcSEcCtD
Isradipine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000647	CcSEcCtD
Isradipine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000409	0.000643	CcSEcCtD
Isradipine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000639	CcSEcCtD
Isradipine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000404	0.000635	CcSEcCtD
Isradipine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000634	CcSEcCtD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	0.000403	0.00283	CbGpPWpGaD
Isradipine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000401	0.000629	CcSEcCtD
Isradipine—CACNA1S—Axon guidance—MET—peripheral nervous system neoplasm	0.000399	0.00279	CbGpPWpGaD
Isradipine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000398	0.000624	CcSEcCtD
Isradipine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.000622	CcSEcCtD
Isradipine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000619	CcSEcCtD
Isradipine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000619	CcSEcCtD
Isradipine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000617	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000615	CcSEcCtD
Isradipine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000612	CcSEcCtD
Isradipine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000607	CcSEcCtD
Isradipine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000606	CcSEcCtD
Isradipine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.000604	CcSEcCtD
Isradipine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.000602	CcSEcCtD
Isradipine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.000595	CcSEcCtD
Isradipine—CACNA1C—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000378	0.00265	CbGpPWpGaD
Isradipine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000594	CcSEcCtD
Isradipine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000594	CcSEcCtD
Isradipine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000591	CcSEcCtD
Isradipine—CACNA1C—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000374	0.00262	CbGpPWpGaD
Isradipine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000587	CcSEcCtD
Isradipine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000584	CcSEcCtD
Isradipine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000582	CcSEcCtD
Isradipine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000581	CcSEcCtD
Isradipine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000369	0.000579	CcSEcCtD
Isradipine—CACNA1S—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000369	0.00258	CbGpPWpGaD
Isradipine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000367	0.000577	CcSEcCtD
Isradipine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000574	CcSEcCtD
Isradipine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000573	CcSEcCtD
Isradipine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000573	CcSEcCtD
Isradipine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000571	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000569	CcSEcCtD
Isradipine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000566	CcSEcCtD
Isradipine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.00056	CcSEcCtD
Isradipine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000555	CcSEcCtD
Isradipine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000549	CcSEcCtD
Isradipine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000549	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000541	CcSEcCtD
Isradipine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.00054	CcSEcCtD
Isradipine—CACNA1H—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000343	0.00241	CbGpPWpGaD
Isradipine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000539	CcSEcCtD
Isradipine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000538	CcSEcCtD
Isradipine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000537	CcSEcCtD
Isradipine—CACNB2—Axon guidance—MET—peripheral nervous system neoplasm	0.000342	0.00239	CbGpPWpGaD
Isradipine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000536	CcSEcCtD
Isradipine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.000533	CcSEcCtD
Isradipine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000533	CcSEcCtD
Isradipine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000531	CcSEcCtD
Isradipine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000529	CcSEcCtD
Isradipine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000528	CcSEcCtD
Isradipine—CACNA1H—Developmental Biology—MET—peripheral nervous system neoplasm	0.000335	0.00235	CbGpPWpGaD
Isradipine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000523	CcSEcCtD
Isradipine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000516	CcSEcCtD
Isradipine—CACNB2—Metabolism—GNS—peripheral nervous system neoplasm	0.000329	0.0023	CbGpPWpGaD
Isradipine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000513	CcSEcCtD
Isradipine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000512	CcSEcCtD
Isradipine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000512	CcSEcCtD
Isradipine—CACNA1D—Axon guidance—MET—peripheral nervous system neoplasm	0.000324	0.00227	CbGpPWpGaD
Isradipine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000508	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.0005	CcSEcCtD
Isradipine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000497	CcSEcCtD
Isradipine—CACNB2—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000316	0.00221	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NME1—peripheral nervous system neoplasm	0.000315	0.00221	CbGpPWpGaD
Isradipine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000493	CcSEcCtD
Isradipine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.00049	CcSEcCtD
Isradipine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000489	CcSEcCtD
Isradipine—CACNA1D—Metabolism—GNS—peripheral nervous system neoplasm	0.000311	0.00218	CbGpPWpGaD
Isradipine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000488	CcSEcCtD
Isradipine—CACNA1H—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.00031	0.00217	CbGpPWpGaD
Isradipine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000483	CcSEcCtD
Isradipine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000477	CcSEcCtD
Isradipine—CACNB2—Metabolism—COX2—peripheral nervous system neoplasm	0.000303	0.00212	CbGpPWpGaD
Isradipine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000474	CcSEcCtD
Isradipine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000474	CcSEcCtD
Isradipine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000472	CcSEcCtD
Isradipine—CACNA1D—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000299	0.0021	CbGpPWpGaD
Isradipine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.00047	CcSEcCtD
Isradipine—CACNA2D2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000298	0.00209	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NME1—peripheral nervous system neoplasm	0.000298	0.00209	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000291	0.00204	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ENO2—peripheral nervous system neoplasm	0.00029	0.00204	CbGpPWpGaD
Isradipine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000453	CcSEcCtD
Isradipine—CACNA1D—Metabolism—COX2—peripheral nervous system neoplasm	0.000287	0.00201	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MET—peripheral nervous system neoplasm	0.000285	0.00199	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MET—peripheral nervous system neoplasm	0.000284	0.00199	CbGpPWpGaD
Isradipine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000436	CcSEcCtD
Isradipine—CACNA1C—Metabolism—GNS—peripheral nervous system neoplasm	0.000273	0.00192	CbGpPWpGaD
Isradipine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000426	CcSEcCtD
Isradipine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000267	0.00042	CcSEcCtD
Isradipine—CACNA1S—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000263	0.00184	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000263	0.00184	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NME1—peripheral nervous system neoplasm	0.000262	0.00184	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000261	0.00183	CbGpPWpGaD
Isradipine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000406	CcSEcCtD
Isradipine—CACNA1C—Metabolism—COX2—peripheral nervous system neoplasm	0.000252	0.00177	CbGpPWpGaD
Isradipine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000394	CcSEcCtD
Isradipine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000393	CcSEcCtD
Isradipine—CACNB2—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00025	0.00175	CbGpPWpGaD
Isradipine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000389	CcSEcCtD
Isradipine—CACNA2D2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000245	0.00172	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000245	0.00172	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MET—peripheral nervous system neoplasm	0.000244	0.00171	CbGpPWpGaD
Isradipine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000377	CcSEcCtD
Isradipine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000376	CcSEcCtD
Isradipine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000374	CcSEcCtD
Isradipine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000374	CcSEcCtD
Isradipine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000372	CcSEcCtD
Isradipine—CACNA1D—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000237	0.00166	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000234	0.00164	CbGpPWpGaD
Isradipine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000363	CcSEcCtD
Isradipine—CACNA1D—Developmental Biology—MET—peripheral nervous system neoplasm	0.000231	0.00162	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—TH—peripheral nervous system neoplasm	0.000231	0.00162	CbGpPWpGaD
Isradipine—CACNA2D2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000229	0.0016	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000226	0.00158	CbGpPWpGaD
Isradipine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000353	CcSEcCtD
Isradipine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000349	CcSEcCtD
Isradipine—CACNA1S—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000222	0.00155	CbGpPWpGaD
Isradipine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000346	CcSEcCtD
Isradipine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000346	CcSEcCtD
Isradipine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000344	CcSEcCtD
Isradipine—CACNA1D—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000214	0.0015	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000208	0.00146	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000208	0.00146	CbGpPWpGaD
Isradipine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000326	CcSEcCtD
Isradipine—CACNB2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000205	0.00143	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MET—peripheral nervous system neoplasm	0.000203	0.00142	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000199	0.00139	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000191	0.00134	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—NRAS—peripheral nervous system neoplasm	0.00019	0.00133	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ENO2—peripheral nervous system neoplasm	0.000189	0.00132	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000188	0.00132	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000188	0.00132	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000186	0.00131	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000185	0.0013	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—NRAS—peripheral nervous system neoplasm	0.00018	0.00126	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000178	0.00125	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000169	0.00118	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000168	0.00118	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ENO2—peripheral nervous system neoplasm	0.000166	0.00116	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000162	0.00114	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00016	0.00112	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—BCHE—peripheral nervous system neoplasm	0.000159	0.00112	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000158	0.00111	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000158	0.00111	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—TH—peripheral nervous system neoplasm	0.000158	0.00111	CbGpPWpGaD
Isradipine—CACNB2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000157	0.0011	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000152	0.00106	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—TH—peripheral nervous system neoplasm	0.00015	0.00105	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000148	0.00104	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—BCHE—peripheral nervous system neoplasm	0.00014	0.000981	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000139	0.000974	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000136	0.000956	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000136	0.00095	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000134	0.000936	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000132	0.000923	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—TH—peripheral nervous system neoplasm	0.000132	0.000922	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000129	0.000905	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000128	0.0009	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000127	0.000888	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GNAS—peripheral nervous system neoplasm	0.000122	0.000857	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.00012	0.000844	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ABCB1—peripheral nervous system neoplasm	0.00012	0.000841	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000116	0.000811	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000116	0.000811	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000115	0.000807	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000113	0.000791	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GNAS—peripheral nervous system neoplasm	0.000107	0.000753	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000105	0.000739	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000102	0.000716	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.92e-05	0.000695	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.4e-05	0.000658	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.76e-05	0.000614	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.3e-05	0.000581	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—HRAS—peripheral nervous system neoplasm	8.26e-05	0.000579	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.78e-05	0.000545	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—AKT1—peripheral nervous system neoplasm	7.29e-05	0.000511	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	5.63e-05	0.000394	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	5.39e-05	0.000378	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	5.19e-05	0.000364	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—AKT1—peripheral nervous system neoplasm	5.09e-05	0.000356	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—AKT1—peripheral nervous system neoplasm	3.49e-05	0.000244	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.41e-05	0.000239	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—AKT1—peripheral nervous system neoplasm	3.3e-05	0.000231	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—AKT1—peripheral nervous system neoplasm	2.9e-05	0.000203	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.88e-05	0.000202	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.75e-05	0.000193	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.71e-05	0.00019	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.21e-05	0.000155	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.17e-05	0.000152	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	5.97e-06	4.18e-05	CbGpPWpGaD
